Global Lutetium-177 Market - By Application (Cancer Therapy (e.g., Prostate Cancer, Neuroendocrine Tumors), Research & Development, Other Therapeutic Uses), By Type (Carrier-added Lutetium-177, Non-carrier-added Lutetium-177), By End User (Hospitals, Diagnostic Imaging Centers, Radiopharmacy Labs, Research Institutes), By Distribution Channel (Direct Sales, Distributors/Wholesalers, Online Platforms) and Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
| 1. Global Lutetium-177 Market Research Report |
| 1.1 Study Objectives |
| 1.2 Lutetium-177 Market - Overview |
| 1.3 Reasons to Read This Report |
| 1.4 Methodology and Forecast Analysis |
| 2. Global Lutetium-177 Market Research Report - Preface |
| 2.1 Global Lutetium-177 Market Research Report – Detailed Scope and Definitions |
| 2.1.1 By Application |
| 2.1.2 By Type |
| 2.1.3 By End User |
| 2.1.4 By Distribution Channel |
| 2.1.5 By Region |
| 3. Global Lutetium-177 Market Dynamics |
| 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers |
| 3.2. Restraints – By Application, By Type, By End User, By Distribution Channel, By Country |
| 3.3. Opportunities – By Application, By Type, By End User, By Distribution Channel, By Country |
| 3.4. Trends – By Application, By Type, By End User, By Distribution Channel, By Country |
| 3.5. PEST Analysis |
| 3.6. Porters Five Rule Analysis |
| 3.7. Company’s Share Analysis (CSA) by Region or By Country |
| 3.8. Global Lutetium-177 Market Research Report – DROTs Impact Analysis |
| 4. Global Lutetium-177 Market Research Report , Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031 |
| 4.1.Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 4.2.Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation. |
| 4.3.Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031 |
| 4.4.Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5. Global Lutetium-177 Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 5.1 Cancer Therapy (e.g., Prostate Cancer, Neuroendocrine Tumors) |
| 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.1.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.2 Research & Development |
| 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.2.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.3 Other Therapeutic Uses |
| 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.3.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6. Global Lutetium-177 Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 6.1 Carrier-added Lutetium-177 |
| 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.1.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.2 Non-carrier-added Lutetium-177 |
| 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.2.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7. Global Lutetium-177 Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 7.1 Hospitals |
| 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.1.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.2 Diagnostic Imaging Centers |
| 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.2.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.3 Radiopharmacy Labs |
| 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.3.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.4 Research Institutes |
| 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.4.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8. Global Lutetium-177 Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 8.1 Direct Sales |
| 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.1.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.2 Distributors/Wholesalers |
| 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.2.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.3 Online Platforms |
| 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.3.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9. Global Lutetium-177 Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn) |
| 9.1 North America |
| 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.1.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.2 Latin America |
| 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.2.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.3 Europe |
| 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.3.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.4 Asia-Pacific |
| 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.4.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.5 Middle East and Africa |
| 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.5.2 Annual Market Trend Assessment – Year-On-Year (Y-O-Y)(%) Growth Observation |
| 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.6 Global Lutetium-177 Market - Opportunity Analysis Index, By Application, By Type, By End User, By Distribution Channel, and Region, 2024 - 2031 |
| 10. North America Lutetium-177 Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 10.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 10.1.1 Cancer Therapy (e.g., Prostate Cancer, Neuroendocrine Tumors) |
| 10.1.2 Research & Development |
| 10.1.3 Other Therapeutic Uses |
| 10.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 10.2.1 Carrier-added Lutetium-177 |
| 10.2.2 Non-carrier-added Lutetium-177 |
| 10.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 10.3.1 Hospitals |
| 10.3.2 Diagnostic Imaging Centers |
| 10.3.3 Radiopharmacy Labs |
| 10.3.4 Research Institutes |
| 10.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 10.4.1 Direct Sales |
| 10.4.2 Distributors/Wholesalers |
| 10.4.3 Online Platforms |
| 10.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 10.5.1 USA |
| 10.5.2 Canada |
| 10.6 North America Lutetium-177 Market – Opportunity Analysis Index, By Application, By Type, By End User, By Distribution Channel, and Country, 2024 - 2031 |
| 10.7 Regional Trends Analysis |
| 10.8 North America Lutetium-177 Market Research Report - Company Profiles |
| 10.8.1 Company 1 (USA) |
| 10.8.2 Company 2 (Canada) |
| 10.8.3 Company 3 (Canada) |
| 11. Latin America Lutetium-177 Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 11.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 11.1.1 Cancer Therapy (e.g., Prostate Cancer, Neuroendocrine Tumors) |
| 11.1.2 Research & Development |
| 11.1.3 Other Therapeutic Uses |
| 11.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 11.2.1 Carrier-added Lutetium-177 |
| 11.2.2 Non-carrier-added Lutetium-177 |
| 11.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 11.3.1 Hospitals |
| 11.3.2 Diagnostic Imaging Centers |
| 11.3.3 Radiopharmacy Labs |
| 11.3.4 Research Institutes |
| 11.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 11.4.1 Direct Sales |
| 11.4.2 Distributors/Wholesalers |
| 11.4.3 Online Platforms |
| 11.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 11.5.1 Brazil |
| 11.5.2 Mexico |
| 11.5.3 Argentina |
| 11.5.4 Rest of Latin America |
| 11.6 Latin America Lutetium-177 Market – Opportunity Analysis Index, By Application, By Type, By End User, By Distribution Channel, and Country, 2024 - 2031 |
| 11.7 Regional Trends Analysis |
| 11.8 Latin America Lutetium-177 Market Research Report - Company Profiles |
| 12. Europe Lutetium-177 Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 12.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 12.1.1 Cancer Therapy (e.g., Prostate Cancer, Neuroendocrine Tumors) |
| 12.1.2 Research & Development |
| 12.1.3 Other Therapeutic Uses |
| 12.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 12.2.1 Carrier-added Lutetium-177 |
| 12.2.2 Non-carrier-added Lutetium-177 |
| 12.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 12.3.1 Hospitals |
| 12.3.2 Diagnostic Imaging Centers |
| 12.3.3 Radiopharmacy Labs |
| 12.3.4 Research Institutes |
| 12.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 12.4.1 Direct Sales |
| 12.4.2 Distributors/Wholesalers |
| 12.4.3 Online Platforms |
| 12.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 12.5.1 United Kingdom |
| 12.5.2 Germany |
| 12.5.3 France |
| 12.5.4 Spain |
| 12.5.5 Italy |
| 12.5.6 Russia |
| 12.5.7 Rest of Europe |
| 12.6 Europe Lutetium-177 Market – Opportunity Analysis Index, By Application, By Type, By End User, By Distribution Channel, and Country, 2024 - 2031 |
| 12.7 Regional Trends Analysis |
| 12.8 Europe Lutetium-177 Market Research Report - Company Profiles |
| 13. Asia-Pacific Lutetium-177 Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 13.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.1.1 Cancer Therapy (e.g., Prostate Cancer, Neuroendocrine Tumors) |
| 13.1.2 Research & Development |
| 13.1.3 Other Therapeutic Uses |
| 13.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.2.1 Carrier-added Lutetium-177 |
| 13.2.2 Non-carrier-added Lutetium-177 |
| 13.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.3.1 Hospitals |
| 13.3.2 Diagnostic Imaging Centers |
| 13.3.3 Radiopharmacy Labs |
| 13.3.4 Research Institutes |
| 13.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.4.1 Direct Sales |
| 13.4.2 Distributors/Wholesalers |
| 13.4.3 Online Platforms |
| 13.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.5.1 China |
| 13.5.2 Japan |
| 13.5.3 India |
| 13.5.4 Australia & New Zealand |
| 13.5.5 South Korea |
| 13.5.6 Rest of Asia-Pacific |
| 13.6 Asia-Pacific Lutetium-177 Market – Opportunity Analysis Index, By Application, By Type, By End User, By Distribution Channel, and Country, 2024 - 2031 |
| 13.7 Regional Trends Analysis |
| 13.8 Asia-Pacific Lutetium-177 Market Research Report - Company Profiles |
| 14. Middle East and Africa Lutetium-177 Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 14.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.1.1 Cancer Therapy (e.g., Prostate Cancer, Neuroendocrine Tumors) |
| 14.1.2 Research & Development |
| 14.1.3 Other Therapeutic Uses |
| 14.2 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.2.1 Carrier-added Lutetium-177 |
| 14.2.2 Non-carrier-added Lutetium-177 |
| 14.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.3.1 Hospitals |
| 14.3.2 Diagnostic Imaging Centers |
| 14.3.3 Radiopharmacy Labs |
| 14.3.4 Research Institutes |
| 14.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.4.1 Direct Sales |
| 14.4.2 Distributors/Wholesalers |
| 14.4.3 Online Platforms |
| 14.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.5.1 UAE |
| 14.5.2 Saudi Arabia |
| 14.5.3 South Africa |
| 14.5.4 Israel |
| 14.5.5 Egypt |
| 14.5.6 Rest of Middle East and Africa |
| 14.6 Middle East and Africa Lutetium-177 Market – Opportunity Analysis Index, By Application, By Type, By End User, By Distribution Channel, and Country, 2024 - 2031 |
| 14.7 Regional Trends Analysis |
| 14.8 Middle East and Africa Lutetium-177 Market Research Report - Company Profiles |
| 15. Competition Landscape |
| 15.1 Strategic Dashboard of Top Market Players |
| 15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis) |
| 15.2.1 ITM Isotope Technologies Munich SE |
| 15.2.2 Novartis (Advanced Accelerator Applications - AAA) |
| 15.2.3 Radiomedix Inc. |
| 15.2.4 Telix Pharmaceuticals |
| 15.2.5 Eckert & Ziegler Radiopharma GmbH |
| 15.2.6 Curium Pharma |
| 15.2.7 NTP Radioisotopes SOC Ltd. |
| 15.2.8 China Isotope & Radiation Corporation (CIRC) |
| 15.2.9 BWXT Medical |
| 15.2.10 Jubilant Radiopharma |
| 15.2.11 NorthStar Medical Radioisotopes |
| 15.2.12 Australian Nuclear Science and Application Organisation (ANSTO) |
| 15.2.13 Isotopia Molecular Imaging |
| 15.2.14 Trace-Ability Inc. |
| 15.2.15 Cardinal Health. |
| 16. Data Collection Method and Research Approach |
| 17. Principal Presumptions and Acronyms |
Need help?
Chat with our team in a minute.